ELAN PHARMACEUTICAL INVESTMENTS LTD 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Apr 21, 2004
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-19$3.00/sh−31,700$95,100→ 2,388,936 total(indirect: I) - Sale
Common Stock
2004-04-20$3.00/sh−5,000$15,000→ 2,383,936 total(indirect: I) - Sale
Common Stock
2004-04-19$3.05/sh−400$1,220→ 2,429,536 total(indirect: I) - Sale
Common Stock
2004-04-19$3.01/sh−8,000$24,080→ 2,420,636 total(indirect: I) - Sale
Common Stock
2004-04-19$3.04/sh−900$2,736→ 2,428,636 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneifically owned indirectly by Elan Corporation, plc and by its wholly-owned subisidary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subisidary of Elan Intenrational Serives, Ltd.